Benign Prostatic Hyperplasia (BPH)

What is Benign Prostatic Hyperplasia?

Benign Prostatic Hyperplasia (BPH), also known as benign prostatic enlargement, consists of a non-cancerous growth of the prostate gland. The prostate is located immediately below the bladder and surrounds the urethra—the canal that carries urine out of the body.

As men age, natural hormonal changes stimulate the growth of prostate tissue. This increase in volume progressively compresses the urethra and obstructs the flow of urine, forcing the bladder to work harder to empty itself.

Important Clarification: BPH is not Cancer

It is fundamental to emphasize that BPH is a completely benign condition. The enlargement of the prostate is not cancer, does not increase the risk of developing prostate cancer, nor does it transform into malignancy over time. However, because they affect the same gland, both conditions can coexist in the same man, making medical evaluation essential.

BPH is one of the most common clinical conditions in males. Its incidence directly follows the advancement of age:

  • It affects about 50% of men in their 50s;
  • It reaches up to 80-90% of men over 80 years old.
Symptoms of Benign Prostatic Hyperplasia

The symptoms resulting from BPH are clinically designated as Lower Urinary Tract Symptoms (LUTS) and are usually divided into two main groups:

Voiding Symptoms (“Obstructive”)

These arise due to the physical compression exerted by the prostate on the urethra:

  • Difficulty or hesitation in starting urination;
  • Weak, thin, or very slow urinary stream;
  • Intermittent urinary stream (stops and starts several times);
  • Abdominal straining to urinate;
  • A clear sensation that the bladder has not emptied completely;
  • Terminal dribbling (loss of drops of urine at the end of urination).

Storage Symptoms (“Irritative”)

Caused by the changes and chronic effort to which the bladder wall is subjected:

  • Nocturia: The need to wake up several times during the night to urinate, significantly disturbing sleep quality;
  • Increased urinary frequency during the day (going to the bathroom at very short intervals);
  • Urinary urgency (a sudden and compelling need to urinate, difficult to delay);
  • Urge incontinence (involuntary loss of urine if the bathroom is not reached quickly).
Diagnosis of Benign Prostatic Hyperplasia

The diagnosis aims to confirm prostate enlargement, assess the severity of urinary obstruction, measure the impact on quality of life, and exclude other associated pathologies.

Initial Clinical Evaluation

  1. Clinical History and IPSS Questionnaire: Application of the International Prostate Symptom Score (IPSS), a globally standardized questionnaire where the patient scores the severity of their symptoms. It allows for the classification of BPH as mild, moderate, or severe.
  2. Digital Rectal Exam: Allows the urologist to palpate the prostate directly to assess its approximate size, consistency, and immediately rule out the presence of hard nodules suspicious of malignancy.
  3. PSA Analysis and Renal Function: Measuring PSA levels in the blood serves to exclude prostate cancer. Creatinine is also measured to ensure that chronic urinary obstruction is not compromising proper kidney function.

Complementary Diagnostic Tests

  • Prostate and Bladder Ultrasound: Accurately assesses prostate volume (in cubic centimeters or an estimated weight in grams), the state of the bladder walls, and quantifies Post-Void Residual (the volume of urine that remains in the bladder immediately after the patient tries to empty it).
  • Uroflowmetry: A simple and non-invasive test where the patient urinates into a special device that graphically records the speed and strength of the urinary flow. Significantly low peak flows suggest the presence of an obstruction.
Treatments and Surgeries for Benign Prostatic Hyperplasia

1. Lifestyle Changes and Daily Care

For men with mild to moderate symptoms, small modifications in daily habits can significantly relieve urinary discomfort and delay the need for medication:

  • Fluid Control: Reduce the intake of water and other fluids 2 to 3 hours before bedtime to decrease trips to the bathroom during the night.
  • Avoid Irritants: Minimize the consumption of coffee, alcohol, soft drinks, and spicy foods, as they irritate the bladder muscle and worsen urinary urgency.
  • Prevent Constipation: Chronic constipation exerts physical pressure on the urethra, making urination difficult. To avoid it, maintain, for example, a diet rich in fiber.
  • Physical Activity: Avoid spending many consecutive hours sitting (pelvic congestion) and practice moderate exercise, helping to control weight.

2. Medical Treatment (Pharmacotherapy)

For mild to moderate symptoms, the first line of approach is usually pharmacological:

  • Alpha-blockers (e.g., tamsulosin, silodosin): Relax the muscle fibers of the bladder neck and prostate, widening the urinary canal. They offer rapid relief of urinary flow (within a few days).
  • 5-alpha-reductase inhibitors (e.g., finasteride, dutasteride): Block the hormonal changes responsible for prostate growth, managing to reduce the volume of the gland by about 20-25% in the long term (6 to 12 months).
  • Phosphodiesterase-5 / PDE5 inhibitors (e.g., tadalafil 5 mg daily): Act by relaxing the smooth muscle cells of the prostate and bladder, improving urinary flow. They offer the significant advantage of simultaneously treating Benign Prostatic Hyperplasia and Erectile Dysfunction, making them an excellent option for men who value the preservation of sexual function.
  • Anticholinergics (e.g., solifenacin, tolterodine) and Beta-3 Agonists (e.g., mirabegron, vibegron): These are drugs specifically targeted at the bladder. They act by stabilizing the detrusor muscle (the bladder muscle), being fundamental for controlling irritative symptoms of urinary urgency, increased frequency, and incontinence.
  • Combination Therapy: It is very common to associate two of these drugs (for example, an alpha-blocker with a 5-alpha-reductase inhibitor or with a beta-3 agonist) to obtain a synergistic effect: clearing the canal and, at the same time, calming bladder urgency.

3. Surgical Techniques and Laser Approaches (Endoscopic)

When medications are no longer effective or complications arise, the removal of obstructive prostatic tissue (adenoma) is chosen, keeping the outer capsule of the prostate intact. Thanks to technology, today this process is often done without skin incisions.

  • Transurethral Resection of the Prostate (Bipolar TURP): This is the evolution of classic standard surgery. Through the urethra, the surgeon uses electrical energy to cut the excess obstructive tissue into small fragments. It is indicated primarily for small to moderate-sized prostates.
  • Photoselective Vaporization with Greenlight Laser: This technique uses a high-precision green laser that is specifically absorbed by the blood in the prostate tissue. Instead of cutting, the Greenlight vaporizes the obstructive tissue and simultaneously cauterizes the blood vessels. This translates into virtually zero risk of bleeding, making it the ideal treatment for cardiac patients or those taking anticoagulant and antiplatelet medications. The hospitalization time and the use of a catheter are drastically reduced.
  • Holmium Laser Enucleation of the Prostate (HoLEP / ThuLEP): Performed endoscopically, it uses a high-power laser to detach and remove the adenoma completely, as if separating the segments from the inside of an orange. It is a highly effective technique, recommended for large-volume prostates, offering a very fast recovery.

4. Next-Generation Autonomous Robotic Procedures (MIST)

These options aim to clear the urinary canal while maximizing safety and preserving the patient’s quality of life.

  • Aquablation (Robotic-Guided Waterjet Ablation): This is one of the greatest innovations in modern urology. It is a minimally invasive procedure that combines real-time ultrasound mapping with the precision of an autonomous robotic arm. The surgeon draws the exact area to be removed on the console, and the robot uses a high-speed waterjet (without heat) to sculpt and remove the obstructive tissue. By avoiding thermal energy, Aquablation offers an exceptionally high rate of preservation of sexual function and normal ejaculation, with high efficacy.
  • Rezum System (Water Vapor Therapy): Indicated for quick interventions in an outpatient setting or with a very short hospital stay. It consists of injecting water vapor directly into the obstructive tissue through a special needle via an endoscopic route. The vapor destroys the cells of the prostatic adenoma, which are progressively reabsorbed by the body over the weeks, freeing the urinary canal.

5. Minimally Invasive Surgery for Large Volume Prostates (Simple Prostatectomy)

When the prostate reaches very high volumes (generally above 80-100 cc), conventional endoscopic surgery may not be the ideal approach. Currently, classic open surgery (which required a large incision in the abdomen and long hospital stays) is being progressively replaced with great success by minimally invasive routes:

  • Laparoscopic and Robotic Simple Prostatectomy: Through small holes in the abdominal wall (often enhanced by the millimeter precision and 3D vision of robotic surgery), the urologist can access the prostate and remove the entire large adenoma in a controlled manner.
  • Advantages: This approach offers the excellent success rates of classic surgery, but with drastically lower blood loss, much less postoperative pain, almost imperceptible scars, shorter hospital stays, and a much faster return to active and professional life.
Regain control of your urinary health.
If you feel a weak urinary stream or go to the bathroom too often, have a precise diagnostic evaluation and learn about the most suitable medical and minimally invasive treatments for your case.

Appointment booking

Book your urology appointment with Dr Frederico Furriel, a urologist with consultations in Leiria, Caldas da Rainha and Porto de Mós. Select your preferred location and submit your appointment request.